MARTINOTTI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 30.631
AS - Asia 14.674
EU - Europa 14.037
SA - Sud America 3.449
Continente sconosciuto - Info sul continente non disponibili 1.414
AF - Africa 320
OC - Oceania 38
Totale 64.563
Nazione #
US - Stati Uniti d'America 29.843
SG - Singapore 5.658
IT - Italia 4.287
CN - Cina 3.601
BR - Brasile 2.775
IE - Irlanda 1.871
VN - Vietnam 1.812
RU - Federazione Russa 1.749
UA - Ucraina 1.628
TR - Turchia 1.489
DE - Germania 1.092
SE - Svezia 886
GB - Regno Unito 767
FI - Finlandia 500
FR - Francia 474
BD - Bangladesh 449
IN - India 423
CA - Canada 392
HK - Hong Kong 381
AR - Argentina 246
MX - Messico 183
EC - Ecuador 128
NL - Olanda 126
JP - Giappone 124
AT - Austria 118
IQ - Iraq 115
ID - Indonesia 113
ES - Italia 111
ZA - Sudafrica 110
KR - Corea 103
PL - Polonia 98
CO - Colombia 88
PK - Pakistan 59
PY - Paraguay 53
VE - Venezuela 47
CL - Cile 46
GR - Grecia 46
MA - Marocco 43
JM - Giamaica 41
UZ - Uzbekistan 40
CR - Costa Rica 39
LT - Lituania 38
BE - Belgio 37
CZ - Repubblica Ceca 36
EG - Egitto 34
KE - Kenya 34
SA - Arabia Saudita 33
AU - Australia 32
EU - Europa 32
IL - Israele 30
HN - Honduras 29
JO - Giordania 29
TN - Tunisia 28
IR - Iran 25
HU - Ungheria 24
UY - Uruguay 24
PE - Perù 23
CH - Svizzera 22
AE - Emirati Arabi Uniti 21
GT - Guatemala 19
RO - Romania 19
DZ - Algeria 18
MY - Malesia 18
TT - Trinidad e Tobago 18
PH - Filippine 17
EE - Estonia 16
BO - Bolivia 14
AZ - Azerbaigian 13
BG - Bulgaria 12
KZ - Kazakistan 12
NI - Nicaragua 12
BY - Bielorussia 11
DO - Repubblica Dominicana 11
PT - Portogallo 11
AL - Albania 10
LB - Libano 10
NP - Nepal 10
OM - Oman 10
SV - El Salvador 10
PS - Palestinian Territory 9
TH - Thailandia 9
TW - Taiwan 9
DK - Danimarca 8
HR - Croazia 8
CI - Costa d'Avorio 7
NG - Nigeria 7
PR - Porto Rico 7
SY - Repubblica araba siriana 7
AM - Armenia 6
BB - Barbados 6
BH - Bahrain 6
ET - Etiopia 6
LV - Lettonia 6
RS - Serbia 6
SN - Senegal 6
KG - Kirghizistan 5
KW - Kuwait 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
BS - Bahamas 4
Totale 63.093
Città #
Singapore 4.122
San Jose 3.076
Jacksonville 2.175
Dublin 1.851
Ashburn 1.762
Chandler 1.640
Council Bluffs 1.576
Dallas 1.188
Princeton 1.007
Beijing 743
Los Angeles 689
Izmir 643
Ho Chi Minh City 632
Nanjing 620
Santa Clara 516
The Dalles 491
New York 481
Rome 393
Hanoi 376
Wilmington 356
Altamura 354
Hong Kong 352
Cambridge 349
Buffalo 336
Southend 319
Munich 315
São Paulo 285
Tongling 260
Nanchang 247
Milan 228
Dearborn 215
Redondo Beach 214
Chieti 195
Atlanta 192
Phoenix 191
Orem 171
Denver 165
Moscow 162
Boardman 148
Chicago 130
Shenyang 122
San Francisco 120
Brooklyn 119
Ann Arbor 118
Toronto 110
Montreal 107
Columbus 105
Tokyo 103
Washington 103
Da Nang 95
Houston 95
Tianjin 92
Hebei 91
Kunming 91
Hefei 89
Grevenbroich 87
Pescara 86
Warsaw 80
Nuremberg 79
Chennai 75
Turku 75
London 74
Rio de Janeiro 73
Vienna 73
Norwalk 70
Haiphong 69
Woodbridge 69
Helsinki 68
Jiaxing 68
Boston 67
Johannesburg 67
Changsha 64
Frankfurt am Main 62
Seattle 62
Mexico City 61
Naples 59
Stockholm 57
Belo Horizonte 55
Brasília 52
Florence 52
Memphis 50
Mount Pleasant 49
Seoul 49
Baghdad 46
Guayaquil 46
Kingston 46
Manchester 46
Bologna 45
Hải Dương 43
Lappeenranta 43
Salvador 43
Hangzhou 42
Mumbai 41
Quito 41
Biên Hòa 40
Teramo 40
Turin 40
Camerino 39
Curitiba 39
Pune 39
Totale 33.296
Nome #
The benzydamine experience: a systematic review of benzydamine abuse 1.131
Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus group 930
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review 786
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 610
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach 568
Alexithymia and suicide risk in psychiatric disorders: A mini-review 537
“Purple Drank” (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications 517
Comparing efficacy of serotonergic, opioidergic, and glutamatergic drugs in gambling disorder: A pooled analysis of response trajectories versus placebo 513
Misuse of Anticholinergic Medications: A Systematic Review 487
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis 439
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 273
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 267
Il corpo nell’esperienza del tossicomane 260
L’ossessione del mangiare sano: la misurazione dell’ortoressia nervosa attraverso la scala ortho-15 259
Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic Efficacy 253
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 253
Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report 247
Metereopatia e metereosensibilità in un campione di pazienti con Disturbo Bipolare: correlazioni con dimensioni temperamentali e caratteriali 244
Alessitimia, lamentele somatiche e sintomi depressivi in adolescenza: risultati preliminari di uno studio longitudinale 232
Transcranial Direct Current Stimulation in Substance Use Disorders: A Systematic Review of Scientific Literature 219
Resilience and cross-network connectivity: A neural model for post-trauma survival 213
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective 210
Self-disturbance in first-episode psychosis: Theoretical framework and potential cannabis interactions - a systematic review 208
Exploring dopaminergic transmission in gambling addiction: A systematic translational review 208
Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics 206
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 200
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 196
The bridge between two worlds: Psychoanalysis and fMRI 194
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study 190
Psicopatologia in slides 190
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 189
Alcohol drinking patterns in young people: A survey-based study 189
25C-NBOMe: Preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug 183
Hallucinogen persisting perception disorder: Etiology, clinical features, and therapeutic perspectives 182
The role of inhaled loxapine in the treatment of acute agitation in patients with psychiatric disorders: A clinical review 179
Captagon: use and trade in the Middle East 177
Agomelatine Effectiveness, Tolerability, and Impact on Anhedonia in Major Depression: A Pooled Analysis 176
Transcranial Direct Current Stimulation Reduces Craving in Substance Use Disorders: A Double-blind, Placebo-Controlled Study 174
Euthymic bipolar disorder patients and EEG microstates: a neural signature of their abnormal self experience? 173
A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015 172
Gambling disorder: Clinical, preventive and organizational implications 171
Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries 169
Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza 168
Hikikomori: psychopathology and differential diagnosis of a condition with epidemic diffusion 168
Fenomenologia della corporeità: dalla psicopatologia alla clinica 166
Alcolismo e famiglia 166
Body representations and basic symptoms in schizophrenia 166
Cognitive dynamics of intertemporal choice in gambling disorder 164
The novel antipsychotic cariprazine (RGH-188): State-of-the-art in the treatment of psychiatric disorders 160
Substance Use in the Club Scene of Rome: A Pilot Study 160
Pharmacological treatments in gambling disorder: A qualitative review 160
Characterizing the building blocks of Problematic Use of the Internet (PUI): The role of obsessional impulses and impulsivity traits among Italian young adults 160
Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study 160
An update of safety of clinically used atypical antipsychotics 159
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder: A Pilot Study 158
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials 157
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 157
Novel psychoactive substances: Use and knowledge among adolescents and young adults in urban and rural areas 157
Depressive symptoms in adolescence: the role of gender and personality traits 156
First-generation antipsychotics and QTc: any role for mediating variables? 155
Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review 154
Integrative processing of touch and affect in social perception: An fMRI study 154
The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study 154
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion 153
Augmentation con aripiprazolo nella depressione maggiore resistente al trattamento: risultati preliminari di uno studio in aperto con dose fissa 152
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 152
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction 152
Novel psychoactive substances in young adults with and without psychiatric comorbidities 152
Current and future perspectives on the major depressive disorder: Focus on the new multimodal antidepressant vortioxetine 151
Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia 151
Aggiunta di memantina alla terapia corrente con donezepil in pazienti con demenza di Alzheimer: effetto sui sintomi psicologici e comportamentali associati alla demenza 150
Alexithymia, suicide risk and serum lipid levels among adult outpatients with panic disorder 150
Peripersonal space boundary in schizotypy and schizophrenia 150
First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation 150
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 149
Substance Use in Schizophrenia: Efficacy of Atypical Antipsychotics 147
New drugs on the internet: The case of Camfetamine 147
Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence 147
BDNF concentration and impulsiveness level in post-traumatic stress disorder 147
Treatment of antipsychotic-induced hyperprolactinemia: An update on the role of the dopaminergic receptors D2 partial agonist aripiprazole 146
Body-environment integration: Temporal processing of tactile and auditory inputs along the schizophrenia continuum 146
Trauma e ambiente: metereopatia e metereosensibilità nei disturbi affettivi e d'ansia 145
Inflammatory markers and suicidal attempts in depressed patients: A review 145
Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction 144
Acute Alcoholic Hallucinosis: A Review 144
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 143
Creativity and psychiatric illness: A functional perspective beyond chaos 143
Gambling and suicide: The socio-anthropological perspective 143
Aggiunta di memantina alla terapia corrente con donepezil in pazienti con demenza di Alzheimer: effetto sui sintomi psicologici e comportamentali associati alla demenza 142
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 142
Transcranial Electrical and Magnetic Stimulation (tES and TMS) for Addiction Medicine: A consensus paper on the present state of the science and the road ahead 142
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 141
Gambling disorder and bilateral transcranial direct current stimulation: A case report 141
An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression 141
Sleep disturbances in eating disorders: a review 140
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world,” everyday clinical practice 140
Sudden cardiac death related to antipsychotics: Beyond the long QT syndrome hypothesis 138
Upcoming tactile events and body ownership in schizophrenia 137
Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally? 137
Major depressive disorder, anhedonia and agomelatine: an open-label study. 136
Totale 21.909
Categoria #
all - tutte 253.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.768 0 0 0 170 90 47 91 160 180 66 236 728
2022/20235.338 604 826 271 468 445 1.048 429 368 562 66 159 92
2023/20243.233 187 132 213 108 183 830 683 218 65 113 96 405
2024/20258.343 561 1.248 949 226 162 323 425 433 933 643 1.003 1.437
2025/202622.279 1.429 815 2.586 3.699 1.632 1.029 2.461 1.446 2.342 1.843 1.888 1.109
2026/202711.166 1.948 4.096 3.026 2.096 0 0 0 0 0 0 0 0
Totale 64.563